(Alliance News) - International Biotechnology Trust PLC on Tuesday said it outperformed its reference index in the first half of the year despite market jitters. Read More
International Biotechnology Trust PLC - London-based investment trust - Notes sale of investee Intra-Cellular Therapies Inc to Johnson & Johnson. Says price of USD132 per share, total USD14.6 billion, represents a premium of approximately 40% to its closing share price on January 10. ITCI represents 7.1% of IBT's net asset value and is its largest shareholding. Read More
(Alliance News) - International Biotechnology Trust PLC on Tuesday said profit soared five times higher during its most recent financial year, as the biotechnology sector begins to shows signs of recovery. Read More
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and Tuesday not separately reported by Alliance News: Read More
(Alliance News) - International Biotechnology Trust PLC on Monday said it received a notice of termination from investment manager SV Health Managers LLP, which said it wants to focus on its core healthcare venture business. Read More